佰仁医疗 (688198)
Beijing Balance Medical Technology Co., Ltd.
K-Line Chart
No K-line data available
Company NameBeijing Bairen Medical Technology Co., Ltd.
Listing Date2019-12-09
Issue Price23.68RMB
Registered Capital13739.514810k RMB
Legal RepresentativeJin Lei
Registered AddressNo. 2 Huachang Road, East District of Science Park, Changping District, Beijing
IndustryMedical Devices
Main BusinessThe company is a domestically technologically leading high-tech enterprise focused on the research, development, and production of animal-derived implantable/interventional medical devices. Its products are used in heart valve replacement and repair, interventional treatment for congenital heart disease, and surgical soft tissue repair.
Company ProfileBeijing Bairen Medical Technology Co., Ltd. (hereinafter referred to as "Bairen Medical" or "the Company") was founded in 2005. The company is a domestically technologically leading high-tech enterprise focused on the research, development, and production of animal-derived implantable/interventional medical devices. Its products are used in heart valve replacement and repair, interventional treatment for congenital heart disease, and surgical soft tissue repair. The company has obtained approval for the registration of 10 Class III medical device products, among which 5 products—including artificial biological heart valves (bovine pericardial valve, porcine aortic valve), pulmonary artery valved conduit, valve annuloplasty ring, and cardiothoracic surgical biological patches—are the first of their kind approved for registration in China, filling domestic gaps. The company's products have been clinically applied in over 300 domestic tertiary hospitals, including Beijing Anzhen Hospital, PLA 301 Hospital, Zhongshan Hospital Affiliated to Fudan University, Guangdong Provincial People's Hospital, Henan Provincial People's Hospital, West China Hospital of Sichuan University, General Hospital of Shenyang Military Region, and Shanghai Children's Medical Center.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Automobile Co., Ltd.
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was established with Beijing Capital Venture Group as the main sponsor....
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5,000 | 10.2 |
| 2 | China Asset Management Co., Ltd. | Public Fund | 3,200 | 6.5 |
| 3 | Hillhouse Capital Management | Private Equity Fund | 2,800 | 5.7 |
| 4 | National Social Security Fund | National Team | 2,500 | 5.1 |
| 5 | E Fund Management Co., Ltd. | Public Fund | 2,000 | 4.1 |
| 6 | China Universal Asset Management Co., Ltd. | Public Fund | 1,800 | 3.7 |
| 7 | CITIC Securities Co., Ltd. | Broker | 1,500 | 3.1 |
| 8 | Guotai Junan Securities Co., Ltd. | Broker | 1,200 | 2.4 |
| 9 | China Merchants Bank | Bank | 1,000 | 2.0 |
| 10 | ICBC Credit Suisse Asset Management Co., Ltd. | Public Fund | 900 | 1.8 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicles
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles (IoV)
Remarks
- Data update date: 2025-11-02
- Data source: Public market information